Paeoniflorin Enhances the Sensitivity of ER-Positive Breast Cancer Cells to Tamoxifen through Promoting Sirtuin 4

Tamoxifen is an effective drug for treating patients with advanced estrogen receptor-positive (ER+) breast cancer (BC), but not for all ER + BC patients. Drug tolerance is the biggest obstacle. In this study, we designed an experiment to investigate whether paeoniflorin affects the ER + BC cell'...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pei, Wu, Nan, Song, Zhi-Jun, Tai, Zheng-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831046/
https://www.ncbi.nlm.nih.gov/pubmed/35154350
http://dx.doi.org/10.1155/2022/6730559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831046/
https://www.ncbi.nlm.nih.gov/pubmed/35154350
http://dx.doi.org/10.1155/2022/6730559

Ejemplares similares